Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Transgender individuals may face specific skin issues during gender-affirming treatments, needing personalized care.

Estrogen therapy can help stabilize the hairline in transfeminine individuals.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Facial feminization surgery is safe and patients are satisfied, but more detailed research is needed.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

As women age, they experience changes in hair density and volume, face challenges in distinguishing normal hair loss from disease, and have limited access to treatments for hair issues.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

More research is needed to improve lower body gender affirmation techniques.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

Eating disorders in gender dysphoria patients may be a coping mechanism for body image issues.

Long-pulsed ruby laser effectively reduces hair in male-to-female transsexuals.

Hair transplants are effective for some women and many male-to-female transgender patients if done carefully by an experienced team.

Transgender acne treatment requires a tailored approach with ongoing topical treatments and ceramide-rich moisturizers.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.